Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy.

Mario Eisenberger is an Oncologist in Baltimore, Maryland. Dr. Eisenberger is rated as an Elite provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Familial Prostate Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.

Laura Sena, MD, PhD is a medical oncologist specializing in the care of patients with advanced prostate cancer at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University. She obtained MD and PhD degrees from Northwestern University in the Medical Scientist Training Program, then subsequently completed Internal Medicine and Medical Oncology subspecialty training in the Physician Scientist Training Program at Johns Hopkins. The goal of her research is to improve therapies and outcomes for patients with advanced prostate cancer by better understanding how prostate cancer metabolism contributes to disease progression, therapeutic resistance, and tumor immune evasion. Dr. Sena is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, and Hormone Replacement Therapy (HRT).

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Hypogonadism, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Dr. Marisa Clifton is the Director of Women’s Health at the Brady Urological Institute. She is fellowship trained. As a leader in the field of female urology, her clinical expertise includes surgical and nonsurgical treatment of pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, urinary fistulas, genitourinary reconstruction and urethral diverticula. Dr. Clifton is also an Assistant Professor of Urology at the Johns Hopkins School of Medicine and serves as the Director of Robotic Education. In addition, she serves as Vice President of Medical Affairs at Johns Hopkins Bayview Medical Center. She also serves as Associate Chief Medical Officer of The Johns Hopkins Hospital. Her research interests include medical education and clinical outcomes after surgery. Dr. Clifton received her medical degree from the Johns Hopkins University School of Medicine and completed her residency in urology at the Mayo Clinic in Rochester, Minnesota. She completed her fellowship in Female Pelvic Medicine and Reconstructive Surgery at The Cleveland Clinic in Cleveland, Ohio. Dr. Clifton is rated as a Distinguished provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Urinary Incontinence, Obstructive Uropathy, Neurogenic Bladder, Sacral Nerve Stimulation, and Hormone Replacement Therapy (HRT).

Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Fateh Hraky is an Obstetrics and Gynecologist in Glen Burnie, Maryland. Dr. Hraky is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Amenorrhea, Vaginal Bleeding Between Periods, Menorrhagia, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT). Dr. Hraky is currently accepting new patients.

Adegboyega Adejana is an Obstetrics and Gynecologist in Glen Burnie, Maryland. Dr. Adejana is rated as an Advanced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Menorrhagia, Amenorrhea, Pelvic Inflammatory Disease, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion. Dr. Adejana is currently accepting new patients.

Arthur Burnett is an Urologist in Baltimore, Maryland. Dr. Burnett is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Dr. Malinda Wu is a pediatric endocrinologist seeing patients at the Johns Hopkins Children’s Center in Baltimore, Maryland. She specializes in a wide range of pediatric endocrine conditions including metabolic bone disease, pediatric osteoporosis and cystic fibrosis endocrinopathies. Dr. Wu received her M.D. from Jefferson Medical College, Thomas Jefferson University. She completed pediatrics residency at Penn State Hershey Medical Center and her pediatric endocrine fellowship at Emory University School of Medicine. She received her Master of Science in Clinical Research from Emory University (2021). Dr. Wu has been a faculty member at Johns Hopkins since 2021. Dr. Wu’s research interests are in metabolic bone disease and the health of women with cystic fibrosis. Dr. Wu’s current research is focused on women with cystic fibrosis and how estrogen supplementation may impact their health. She has received grant funding from the Cystic Fibrosis Foundation. Dr. Wu is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Osteogenesis Imperfecta, Hypogonadism, Malnutrition, Exocrine Pancreatic Insufficiency, and Hormone Replacement Therapy (HRT).

Dr. Cybill Esguerra is a clinical instructor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine. Her clinical interests and expertise include general obstetrics, well-woman care, menstrual disorders, contraceptive management, adolescent gynecology, and gynecologic surgery. Dr. Esguerra attended medical school at Saint Louis University School of Medicine and completed her residency in Obstetrics and Gynecology at Robert Wood Johnson University Hospital New Brunswick in New Jersey where she served as Administrative Chief Resident. Dr. Esguerra chose to practice Obstetrics and Gynecology in order to provide continuity of care throughout a woman's lifetime. She strives to deliver compassionate, patient-centered care at the highest medical standards. Outside of the office, Dr. Esguerra enjoys Pilates and exploring new cities. Recent News Articles and Media Coverage Pool Cannonballs Are Pretty Much A No-Go During Pregnancy, Romper (May 2021) The Best Menstrual Cups of 2021, Reviewed (May 2021). Dr. Esguerra is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Tubal Ligation and Hormone Replacement Therapy (HRT).

Dr. Errol L. Fields is an Associate Professor of Pediatrics in the Division of Adolescent/Young Adult Medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Bloomberg School of Public Health’s Department of Health, Behavior and Society. A physician-researcher, Dr. Fields is a pediatrician and adolescent medicine subspecialist. He provides primary care and subspecialty consultative care to adolescents and young adults including inclusive sexual and reproductive health care and treatment and prevention of HIV and other sexually transmitted infections His research focuses on using mixed methodologies to understand and reduce HIV disparities among adolescent and young adult Black gay, bisexual and other men who have sex with men (MSM) as well as the evaluation of community-engaged practices for reducing stigma and medical distrust as key barriers to HIV prevention, treatment and research. Dr. Fields is also committed to the provision of evidence-based, culturally competent care of sexual and gender minority youth and is involved in undergraduate, graduate, and continuing medical education in this area. Dr. Fields began his training in research and public health while completing a master of public health at Columbia University Mailman School of Public Health. He continued his education and training in the Medical Scientist Training Program at Johns Hopkins, where he earned his medical doctorate and his doctorate in philosophy from the School of Medicine and Bloomberg School of Public Health respectively. He completed pediatric residency training at Boston Children’s Hospital and Boston Medical Center and his subspecialty fellowship training in adolescent medicine at Johns Hopkins School of Medicine. Dr. Fields is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are HIV/AIDS and Hormone Replacement Therapy (HRT).

David Kamson is an Oncologist in Baltimore, Maryland. Dr. Kamson is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Brain Tumor, Glioblastoma, Gliosarcoma, Metastatic Brain Tumor, and Hormone Replacement Therapy (HRT).

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Dr. Shadpour Demehri is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He specializes in diagnostic radiology and musculoskeletal (MSK) radiology. Dr. Demehri received his M.D. from Tehran University School of Medicine in 2003. He completed a fellowship in radiology at Johns Hopkins University School of Medicine. He performed his residency in diagnostic radiology in 2010 at Brigham & Women’s Hospital, where he subsequently completed two fellowships, one in musculoskeletal and nuclear radiology and a second in noninvasive cardiovascular imaging. He joined the Johns Hopkins faculty in September 2012. Dr. Demehri is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Ollier Disease, Osteotomy, and Aneurysm Repair.

Dr. Marlene Stephanie Williams is an Associate professor at the Johns Hopkins University School of Medicine. Her research focuses on coronary atherosclerosis and platelet function, and her particular focus is on platelet function as it relates to the acute coronary syndrome. Dr. Williams has examined platelet function and its correlation to platelet functional genomics and runs a platelet physiology laboratory on the Johns Hopkins Bayview campus. The goal for her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may improve this dysfunction that may eventually be translated to therapies for patients with cardiovascular disease. She is a prior recipient of an NIH career mentored award (K23) examining platelet functional genomics and an NIH RO1 award addressing platelet serotonin signaling in depression and heart disease. Dr. Williams has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, and heart disease and depression. She has participated in several NHLBI advisory committees, review groups, and study sections. Dr. Williams has been the Course Director, of the advanced clinical clerkship in coronary intensive care at the Bayview Medical center and has mentored many medical residents and cardiology fellows. Dr. Williams received her undergraduate degree in biochemistry from McGill University. She earned a medical degree from the Columbia University College of Physicians & Surgeons and completed a residency at Johns Hopkins Hospital. After completing a residency, Dr. Williams was a cardiology fellow at Mount Sinai Hospital and Johns Hopkins Hospital. Dr. Williams is currently the Clinical Director of Cardiology at Johns Hopkins Bayview Medical Center. Dr. Williams is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Pacemaker Implantation, and Hormone Replacement Therapy (HRT).

Pamela Ouyang is a Cardiologist in Baltimore,, Maryland. Dr. Ouyang is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Atherosclerosis, Menopause, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, and Hormone Replacement Therapy (HRT).

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is rated as an Experienced provider by MediFind in Hormone Replacement Therapy (HRT). Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).